Dr. Reddy's Laboratories Ltd. Financial Overview
Dr. Reddy's Laboratories Ltd.'s market cap is currently ₹1.07T. The company's EPS TTM is ₹17.25; its P/E ratio is 18.20; and it has a dividend yield of 0.62%. Dr. Reddy's Laboratories Ltd. is scheduled to report earnings on October 24, 2025, and the estimated EPS forecast is ₹14.86. See an overview of income statement, balance sheet, and cash flow financials.
